When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk has an opportunity to expand indications on its weight loss drugs. Check out on what could be next for NVO stock ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected ...

The task ahead of Vertex now is to migrate patients already on Trikafta to the new drug. That is supported by data from the ...

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

Users of the highly effective drug Ozempic are facing a new terrifying side effect - potential blindness. Reports of an eye-rotting condition linked to the drug are on the rise, raising concerns among ...

Brent crude futures were up 42 cents, or 0.6%, to $73.05 a barrel, and U.S. West Texas Intermediate crude futures rose 38 cents, or 0.6%, to $69.62 a barrel at 0742 GMT.

The FDA initially rejected the marketing application for Alhemo in 2022, asking for additional data on dosing and monitoring.

While the amended Law on Pharmacy 2024 is expected to facilitate future performance of foreign-invested enterprises, it might ...

Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...

European markets opened higher on Tuesday, in a shortened trading session for Christmas Eve. At the opening bell, the ...